Underdosing of other estrogens and progestogens, subs encntr

This code indicates that a patient is experiencing adverse effects or complications due to receiving an insufficient amount of estrogen or progestogen medication. This underdosing could be intentional (e.g., dose reduction) or unintentional (e.g., patient non-adherence, malabsorption), leading to a recurrence or worsening of the condition the medication was intended to treat.

Apply this code when documenting a patient visit for follow-up care related to the underdosing of estrogen or progestogen, after the initial treatment for the underdosing has already begun. This typically involves managing ongoing symptoms or adjusting medication regimens in response to the insufficient dosage. Examples include a patient returning for a re-evaluation after their hormone replacement therapy dose was reduced, or a patient experiencing breakthrough bleeding due to inconsistent oral contraceptive use.

• Always use an additional code to specify the nature of the adverse effect or the underlying condition being treated.
• Ensure documentation clearly supports that this is a subsequent encounter, meaning the patient is receiving continuing care for the underdosing.
• Distinguish from initial encounters (T38.5X1-) or sequela (T38.5XS-) based on the stage of care.